Digital & Innovation
Key recommendations for data access to modernise Australia’s healthcare system post COVID-19

Almost every industry and every Australian has been impacted in some way by COVID-19. Changes to the healthcare industry have included restrictions and reductions in medical services, and limitations on certain medicines. As a result, the Senate established a Committee to inquire into the Australian Government’s response to the COVID-19 pandemic.
In an interview with Health Industry Hub, Dr Peter Cronin, Co-Founder and Head of Data and Partnerships at Prospection, welcomed the inquiry and discussed Prospection’s submission and key recommendations focusing on Why healthcare data access is critical.
Interview with Dr Peter Cronin
Co-Founder and Head of Data and Partnerships at Prospection
The key recommendations proposed address the critical need for data access in response to the terms of reference of the inquiry into the Australian government’s response to COVID-19.
Prospection is a healthcare data analytics company which uses AI and machine learning to provide real world insights into aggregated patient health journeys. They have worked with government, healthcare, medical research and pharmaceutical industry partners to make real changes to health outcomes with access to health data sets.
Leadership & Management
David Henderson appointed Takeda Oceania Country Head
David Henderson has been appointed Country Head for Takeda Oceania, succeeding Dave Pearce, as the pharmaceutical company continues to reshape […]
MoreNews - Pharmaceuticals
GBMA puts medicine shortages on the table as strategic agreement talks begin
As the Generic and Biosimilar Medicines Association (GBMA) begins negotiations with government on the next strategic agreement, it has unveiled […]
MoreNews - MedTech & Diagnostics
Australia sets a new course for prostate cancer detection
Australia has become one of the first countries in the world to adopt a modern, evidence-based framework for the early […]
MoreNews - Pharmaceuticals
IVF success rates climb as ART sector faces major accreditation overhaul
Australians undergoing in vitro fertilisation (IVF) are now more likely to take home a baby than they were five years […]
More